ArticleTranslational oncology2021

Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression.

Philip Vitorino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.